Yaoyin Zhang
Datos Biográficos
| ID | 7964932 |
|---|---|
| NOMBRE | Yaoyin Zhang |
| NOMBRES | Yaoyin |
| APELLIDO | Zhang |
| FIRMA | ZHANG Y |
| AFILIACIONES | University of Electronic Science and Technology of China |
| VERIFICADO | No |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2020 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2027 |
| ÍNDICE H | 0 |
Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes
Differences in psychometric characteristics of outpatients with somatic symptom disorder from general hospital biomedical (neurology/gastroenterology), traditional Chinese medicine, and psychosomatic …
SSD patients from psychosomatic departments had higher level of somatic symptom severity, depression and anxiety than from TCM and biomedical settings. In our specific sample, a cutoff point of ≥16 for SSD-12 could be recommended in all three settings. But the cutoff point of PHQ-15 differs much between different settings, which was ≥8, 9, and 11 in biomedical, TCM, and psychosomatic settings, respectively
Validation of the Chinese version of the Somatic Symptom Scale-8 in patients from tertiary hospitals in China
Our preliminary assessment suggests that the Chinese language version of the SSS-8 has reliability and validity sufficient to warrant testing further in research and clinical settings
Detecting DSM-5 somatic symptom disorder in general hospitals in China
In general hospital settings, SSD-12 or WI-8 alone may be sufficient for detecting somatic symptom disorder, as effective as when combined with the PHQ-15 or SSS-8 for evaluating physical burden
Validation of the Chinese Version of the Somatic Symptom Disorder–B Criteria Scale for Detecting DSM-5 Somatic Symptom Disorders
OBJECTIVE: This study aimed to validate the Chinese version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in an outpatient sample from Chinese general hospitals and to determine the diagnostic performance of the SSD-12 as a screening tool for somatic symptom disorder (SSD). METHODS: The Chinese version of the SSD-12 was completed by 699 outpatients from nine general hospitals during a 16-month period (2016-2018). The SSD section of th…
Sin obras prominentes en esta página.
Validation of the Chinese Version of the Somatic Symptom Disorder–B Criteria Scale for Detecting DSM-5 Somatic Symptom Disorders
OBJECTIVE: This study aimed to validate the Chinese version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in an outpatient sample from Chinese general hospitals and to determine the diagnostic performance of the SSD-12 as a screening tool for somatic symptom disorder (SSD). METHODS: The Chinese version of the SSD-12 was completed by 699 outpatients from nine general hospitals during a 16-month period (2016-2018). The SSD section of th…
Validation of the Chinese version of the Somatic Symptom Scale-8 in patients from tertiary hospitals in China
Our preliminary assessment suggests that the Chinese language version of the SSS-8 has reliability and validity sufficient to warrant testing further in research and clinical settings
Detecting DSM-5 somatic symptom disorder in general hospitals in China
In general hospital settings, SSD-12 or WI-8 alone may be sufficient for detecting somatic symptom disorder, as effective as when combined with the PHQ-15 or SSS-8 for evaluating physical burden
Differences in psychometric characteristics of outpatients with somatic symptom disorder from general hospital biomedical (neurology/gastroenterology), traditional Chinese medicine, and psychosomatic …
SSD patients from psychosomatic departments had higher level of somatic symptom severity, depression and anxiety than from TCM and biomedical settings. In our specific sample, a cutoff point of ≥16 for SSD-12 could be recommended in all three settings. But the cutoff point of PHQ-15 differs much between different settings, which was ≥8, 9, and 11 in biomedical, TCM, and psychosomatic settings, respectively
Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes
Medicine (4 obras) · Psychosomatic Disorders and Their Treatments (4 obras) · Internal Medicine (3 obras) · Mental Health and Psychiatry (3 obras) · Psychiatry (3 obras) · Anxiety (2 obras) · Clinical Psychology (2 obras) · Family medicine (2 obras) · Fibromyalgia and Chronic Fatigue Syndrome Research (2 obras) · Psychology (2 obras)